JANE STREET GROUP, LLC - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is and the CUSIP is 15678U908. A total of 5 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q2 2024$14,659,065
-8.0%
358,500
-4.9%
0.00%0.0%
Q1 2024$15,927,336
+17.4%
376,800
+17.7%
0.00%
-25.0%
Q4 2023$13,572,240
+653.6%
320,100
+288.0%
0.00%
+300.0%
Q3 2023$1,800,975
-25.8%
82,500
+8.1%
0.00%0.0%
Q2 2023$2,425,577
-38.1%
76,300
-52.5%
0.00%
-50.0%
Q1 2023$3,917,034
+60.7%
160,600
+107.8%
0.00%
+100.0%
Q4 2022$2,438,042
-34.6%
77,300
-41.4%
0.00%
-50.0%
Q3 2022$3,727,000
+1499.6%
131,900
+1398.9%
0.00%
Q2 2022$233,0008,8000.00%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q2 2022
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 243,400$6,435,0000.37%
SIMPLEX TRADING, LLC 4,200$111,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JANE STREET GROUP, LLC 8,800$233,0000.00%
GROUP ONE TRADING LLC 3,000$79,0000.00%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders